Literature DB >> 9606361

Conventional cancer therapy: promise broken or promise delayed?

I F Tannock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9606361     DOI： 10.1016/s0140-6736(98)90327-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.

Authors:  Michael P Hay; Kevin O Hicks; Karin Pchalek; Ho H Lee; Adrian Blaser; Frederik B Pruijn; Robert F Anderson; Sujata S Shinde; William R Wilson; William A Denny
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

2.  Effects of combined sunitinib and extracranial stereotactic radiotherapy on bone marrow hematopoiesis.

Authors:  Johnny Kao; Jonathan Timmins; Junko Ozao-Choy; Stuart Packer
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

Review 3.  The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Authors:  Larry H Matherly; Zhanjun Hou; Aleem Gangjee
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-10       Impact factor: 3.333

4.  Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases.

Authors:  M F Gnant; M Puhlmann; D L Bartlett; H R Alexander
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

5.  Hypoxia enhances the replication of oncolytic herpes simplex virus.

Authors:  Manish K Aghi; Ta-Chiang Liu; Samuel Rabkin; Robert L Martuza
Journal:  Mol Ther       Date:  2008-10-28       Impact factor: 11.454

6.  Hypoxia induces a phase transition within a kinase signaling network in cancer cells.

Authors:  Wei Wei; Qihui Shi; Francoise Remacle; Lidong Qin; David B Shackelford; Young Shik Shin; Paul S Mischel; R D Levine; James R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

7.  The state of academic cancer surgery in the UK.

Authors:  S Eckhouse; R Sullivan
Journal:  Mol Oncol       Date:  2008-06-11       Impact factor: 6.603

8.  Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.

Authors:  Johnny Kao; Stuart Packer; Ha Linh Vu; Myron E Schwartz; Max W Sung; Richard G Stock; Yeh-Chi Lo; Delphine Huang; Shu-Hsia Chen; Jamie A Cesaretti
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

Review 9.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

Review 10.  [Indications for neoadjuvant therapy in rectal carcinoma].

Authors:  F Zimmermann; M Molls
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.